Dilution profile // every instrument, one screen, from SEC filings

Werewolf Therapeutics, Inc. (HOWL)

CIK 1785530 · all EDGAR filings →

Overall dilution risk
HIGHworst of 3 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGHS-3 on file 2025-05-08
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
MEDIUM+36% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
Cash need
HIGH~4.4 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)
the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2021-06-042026-07-27

Latest: 48.6M shares as of Jul 27, 2026 (10-Q).

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

Balance-sheet fair value of warrants: $7.8M as of Jun 1, 2020.

Convertible notes

NotePrincipalCarryingConv. priceRateIf converted
Loan Agreementnot tagged$6.3182

Notes exactly as the company dimensioned them in its 10-Q filed Jul 31, 2026. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.

Registrations and offerings

S-3May 8, 2025no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 0 executed · 0 registered.

EFFECTIVEMay 15, 2025SEC declared a registration effective — selling can beginEFFECT
REGISTEREDMay 8, 2025S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDMar 11, 2025Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5
EXECUTEDFeb 9, 2024Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5
EFFECTIVEMay 20, 2022SEC declared a registration effective — selling can beginEFFECT
REGISTEREDMay 10, 2022S-3 registration — capacity to sell shares, not a sale yetS-3
EXECUTEDApr 30, 2021Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4
REGISTEREDApr 29, 2021S-1MEF registration — capacity to sell shares, not a sale yetS-1MEF
EFFECTIVEApr 29, 2021SEC declared a registration effective — selling can beginEFFECT
REGISTEREDApr 26, 2021S-1/A registration — capacity to sell shares, not a sale yetS-1/A
REGISTEREDApr 8, 2021S-1 registration — capacity to sell shares, not a sale yetS-1

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full HOWL workspace